Medical Digest & Congress Report
Episodes
Randomized Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder Cancer - report from ESMO2024
24 Oct 2024
Contributed by Lukas
Professor Petros Grivas shares his insights on the NIAGARA study. Video: https://medicaldigest.org/scientific-contents/interview:randomized-phase-3-tr...
Adjuvant Pembrolizumab Prolongs DFS Among Patients with High-Risk Muscle Invasive Urothelial Carcinoma - report from ESMO2024
24 Oct 2024
Contributed by Lukas
Professor Petros Grivas shares his insights on the AMBASSADOR study. Video: https://medicaldigest.org/scientific-contents/interview:adjuvant-pembroliz...
Biomarker selected strategies and immunotherapy change the landscape of upper GI tumor treatment - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Yelena Janjigian shares his thoughts on biomarker selected strategies and immunotherapy change the landscape of upper GI tumor treatment fro...
Rise of cancer in young adults - lower GI news from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Dirk Arnold shares his thoughts on lower gastrointestinal news from ESMO2024. Video: https://medicaldigest.org/scientific-contents/interview...
Eyes to the future: Moving towards molecular and AI-driven oncology - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Federica Di Nicolantonio shares his thoughts on the Rome and GigaPath trials and the importance of moving towards molecular and AI-driven on...
Incorporating novel treatment insights for ER+ early BC patients
11 Oct 2024
Contributed by Lukas
Professor Petra Tesarova shares his thoughts on CDK 4-6 inhibitors in early breast cancer. Video: https://medicaldigest.org/scientific-contents/interv...
Novel targeted therapies for pancreatic cancer - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Davide Melisi shares his thoughts on novel targeted therapies for pancreatic cancer. Video: https://medicaldigest.org/scientific-contents/in...
Systemic therapy for organ preservation - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor David Sebag-Montefiore shares his thoughts on systemic therapy for organ preservation and the findings from the NO-CUT trial were presented ...
The Rome Trial From Histology to Target: the Road to Personalize Targeted Therapy and Immunotherapy - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Andrea Botticelli presented the Rome trial results at ESMO 24 Presidential Session. Patients with advanced cancers receiving tumor-agnostic ...
Genitourinary tumours, non-prostate highlights of the ESMO 2024 Congress
11 Oct 2024
Contributed by Lukas
Professor Aristotelis Bamias shares his thoughts on genitourinary tumours highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scien...
Lung cancer interception: New approaches to lung cancer screening and prevention - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Jianjun Zhang shares his thoughts on lung cancer screening and prevention. Video: https://medicaldigest.org/scientific-contents/interview:lu...
Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study
11 Oct 2024
Contributed by Lukas
Professor Domenica Lorusso presented the overall survival results from the randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. Pe...
LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib + Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma - report from ESMO2024
11 Oct 2024
Contributed by Lukas
Professor Josep Llovet discusses the results of LEAP-012 Study which he presented at ESMO 2024. Video: https://medicaldigest.org/scientific-contents/i...
Adding Metformin to ADT for Patients with mHSPC: Overall Survival Results from the Multi-Arm, Multi-Stage Randomized Platform Trial STAMPEDE - report from ESMO2024
28 Sep 2024
Contributed by Lukas
Professor Silke Gillessen discussing results from STAMPEDE trial assessing the addition of metformin to ADT for patients with mHSPC. Video: https://me...
PEACE-3 Trial Shows Combination Therapy Improves Survival in Prostate Cancer - report from ESMO2024
28 Sep 2024
Contributed by Lukas
Professor Silke Gillessen presented new results from the PEACE-3 trial at the 2024 ESMO conference. This study indicates that combining Enzalutamide w...
Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Overall survival results from the phase 3 KEYNOTE-522 study
28 Sep 2024
Contributed by Lukas
Professor Peter Schmid presented the overall survival results from the phase 3 KEYNOTE-522 study at ESMO 2024 Congress. Neoadjuvant pembrolizumab or p...
POD1UM-303/InterAACT 2: Potentially Practice-Changing Findings in SCAC - report from ESMO2024
28 Sep 2024
Contributed by Lukas
Professor Dominik P. Modest shares his thoughts on POD1UM-303/InterAACT 2 study, which are potentially practice-changing findings in squamous cell car...
Setting a new benchmark for ALK+ aNSCLC targeted therapy - report from ESMO2024
28 Sep 2024
Contributed by Lukas
Professor Tony S.K. Mok shares his thoughts on setting a new benchmark for ALK+ aNSCLC targeted therapy. Video: https://medicaldigest.org/scientific-c...
Breast cancer, early stage highlights of the ESMO 2024 Congress
28 Sep 2024
Contributed by Lukas
Professor Ann Partridge shares his thoughts on breast cancer, early stage highlights of the ESMO 2024 Congress. Video: https://medicaldigest.org/scien...
Adjuvant Pembrolizumab/Chemotherapy Misses DFS End Point in High-Risk Endometrial Cancer, but Benefits dMMR Subgroup - report from ESMO2024
28 Sep 2024
Contributed by Lukas
Professor Remi Nout shares his thoughts on the interim results of the phase 3 ENGOT-en11/GOG-3053/KEYNOTE-B21 trial that were presented during the ESM...
Treatment of cervical cancer in 2024 in the highlight of KEYNOTE-A18 study - report from ESMO2024
28 Sep 2024
Contributed by Lukas
Professor Remi Nout shares his thoughts on the treatment of cervical cancer in 2024 in the light of KEYNOTE-A18 study. Video: https://medicaldigest.or...
New pillars of optimal medical treatment in heart failure - report from ESC2024
25 Sep 2024
Contributed by Lukas
Prof. Michael Böhm explains how SGLT-2 inhibitors became a strong pillar of treatment in HFrEF and HFpEF patients. Their antidiabetic effect and kidn...
Highlihts of ERS 2024 - The President's perspective
20 Sep 2024
Contributed by Lukas
Prof. Carlos Robalo Cordeiro, immediate Past-President of the ERS shares his thoughts on the highlights of ERS 2024. Video: https://medicaldigest.org/...
Why is idiopathic pulmonary fibrosis not so idiopathic? - report from ERS2024
20 Sep 2024
Contributed by Lukas
Prof. Michael Kreuter co-chaired a very interesting session at this years ERS congress on novelties in the treatement of interstitial lung diseases an...
Improving Lung Health in the 21st century - report from ERS2024
20 Sep 2024
Contributed by Lukas
Prof. Joan B. Soriano co-chaired a very interesting session at this years ERS congress on the challenges of increasing urbanisation for respiratory he...
Overcoming the challenges of increasing urbanisation for respiratory health - report from ERS2024
19 Sep 2024
Contributed by Lukas
Prof. Ane Johannessen co-chaired an interesting session to identify how future city life around the world may have the potential to improve respirator...
Thoracic oncology - Lung cancer diagnostics and treatment challenges - report from ERS2024
19 Sep 2024
Contributed by Lukas
Prof. Maria Joana Pereira Catarata co-chaired a very interesting session on lung cancer diagnostics and treatment challenges. Video: https://medicaldi...
Novel research data on asthma and chronic obstructive pulmonary disease management: clinical applications - report from ERS2024
19 Sep 2024
Contributed by Lukas
Prof. Charlotte Suppli Ulrik co-chaired a very interesting session at this years ERS congress on novel research data on asthma and chronic obstructive...
COPD in a nutshell at ERS2024
18 Sep 2024
Contributed by Lukas
Prof. Nick Hopkinson shares his thoughts on the challenges and management of COPD. Video: https://medicaldigest.org/scientific-contents/interview:copd...
Paediatric asthma in 2024: from prevention to transition - report from ERS2024
18 Sep 2024
Contributed by Lukas
Prof. Andrew Bush co-chaired a very interesting session on the prevention and treatment of paediatric asthma. Video: https://medicaldigest.org/scienti...
How to change urban areas to improve the life of allergic patients? - report from ERS2024
18 Sep 2024
Contributed by Lukas
Dr. Alessandro Marcon on how to change urban areas to improve the life of allergic patients? Video: https://medicaldigest.org/scientific-contents/inte...
Paediatric asthma in 2024: from prevention to transition - report from ERS2024
18 Sep 2024
Contributed by Lukas
Prof. Angela Zacharasiewicz shares her thoughts on the prevention and treatment of paediatric asthma. To find out more, visit the Children's Bronc...
Smoke-free Europe: utopia or feasible reality? - report from ERS2024
18 Sep 2024
Contributed by Lukas
Prof. Nick Hopkinson on the goal of a smoke-free generation. Video: https://medicaldigest.org/scientific-contents/interview:smoke-free-europe-utopia-o...
Respiratory Medicine against Lung Cancer - report from ERS2024
18 Sep 2024
Contributed by Lukas
Prof. Joanna Chorostowska-Wynimko, President Elect of the European Respiratory Society gave us a brief summary on the state-of-the-art respiratory med...
What is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes? - report from ESC2024
18 Sep 2024
Contributed by Lukas
Professor Marc Bonaca explains what is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes? Video: https://medicaldigest.org...
Pre-diabetes: a risk factor for cardiovascular disease? - report from ESC2024
18 Sep 2024
Contributed by Lukas
Professor Antonio Ceriello co-chaired a very interesting session on prediabetes. He shared his thoughts on the field with us. Video: https://medicaldi...
Patient engagement in lipid-lowering therapies - report from ESC2024
17 Sep 2024
Contributed by Lukas
Professor Vera Bittner shares her experiences in patient engagement in lipid-lowering therapies. Video: https://medicaldigest.org/scientific-contents/...
Guidelines in Practice: implementing the 2023 Focused Update on Heart Failure - target, treat, and titrate - report from ESC2024
17 Sep 2024
Contributed by Lukas
Professor Piotr Ponikowski shares his experiences on ESC Clinical Practice Guidelines in implementing the 2023 Focused Update on Heart Failure. Video:...
Cardiovascular multimorbid patients’ care - report from ESC2024
17 Sep 2024
Contributed by Lukas
Professor Claudio Borghi shares his insights on cardiovascular multimorbid patients’ care. Video: https://medicaldigest.org/scientific-contents/inte...
2024 ESC Guidelines for the Management of Atrial Fibrillation - report from ESC2024
17 Sep 2024
Contributed by Lukas
Professor Isabelle C. Van Gelder co-chaired the guideline task force on the 2024 ESC Guidelines for the Management of Atrial Fibrillation. Video: http...
2024 ESC Guidelines for the Management of Chronic Coronary Syndromes - report from ESC2024
17 Sep 2024
Contributed by Lukas
Professor Christiaan Vrints co-chaired the guideline task force on the 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes. Video: ht...
EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease - report from ESC2024
16 Sep 2024
Contributed by Lukas
Professor Gi-Byoung Nam explains thtat edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agen...
FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials - report from ESC2024
16 Sep 2024
Contributed by Lukas
Professor Muthiah Vaduganathan explains that the FINE-HEART pooled analysis of three large trials failed to demonstrate significant reductions in card...
Chronic ischaemic syndrome management in 2024: are we ready for the (r)evolution? - report from ESC2024
16 Sep 2024
Contributed by Lukas
Professor Mario Marzilli highlights the evolving environment of chronic coronary syndrome management and translates new ESC chronic coronary syndrome ...
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis - report from ESC2024
13 Sep 2024
Contributed by Lukas
Professor Pardeep Jhund explains that mineralocorticoid receptor antagonists reduced the risk of cardiovascular death or heart failure hospitalization...
Guidelines in Practice: cardio-renal protection in patients with diabetes - report from ESC2024
12 Sep 2024
Contributed by Lukas
Professor Ramzi Ajjan shares his insights on cardio-renal protection in patients with diabetes. Video: https://medicaldigest.org/scientific-contents/i...
2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases - report from ESC2024
12 Sep 2024
Contributed by Lukas
Professor José Rodriguez Palomares co-chaired the guideline task force on 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Di...
The Dundee experience: really personalised acute stroke treatment! - report from ESC2024
12 Sep 2024
Contributed by Lukas
Professor Iris Grunwald shares her experience of personalised stroke management. Video: https://medicaldigest.org/scientific-contents/interview:dundee...
Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control - report from ESC2024
12 Sep 2024
Contributed by Lukas
Professor Johanne Silvain presented results of the ABYSS trial in a Hot Line session at ESC Congress 2024. The cardiovascular safety of interrupting b...
ESC Clinical Practice Guidelines 2022 and 2023 for General Practice and General Cardiology: where do we stand? - report from ESC2024
12 Sep 2024
Contributed by Lukas
Professor Konstantinos Toutouzas co-chaired an interresting session for general clinicians the ESC Guidelines on Cardio-Oncology and Management of Car...
Patient with diabetes, heart failure with reduced ejection fraction, and impaired kidney function: how to implement the guidelines and take-home messages - report from ESC2024
11 Sep 2024
Contributed by Lukas
Professor Nikolaus Marx shares his insights on patient with diabetes, heart failure with reduced ejection fraction, and impaired kidney function. How ...
Clash of the titans: when cardiovascular and kidney diseases overlap - report from ESC2024
10 Sep 2024
Contributed by Lukas
Professor Roser Torra shares his insigths od o ESC joint session with the European Renal Association as well as the four foundational therapies availa...
Chronic coronary syndrome: the journey so far and the road to the future - report from ESC2024
10 Sep 2024
Contributed by Lukas
Professor Athanasios John Manolis provides an overview of current guidelines recommendations and the importance of an individualized patient-centered ...
Clinical trial updates on the GLP-1 receptor agonists - report from ESC2024
10 Sep 2024
Contributed by Lukas
Professor Mikhail Kosiborod provides a summary of the clinical trial updates on the GLP-1 receptor agonists. Video: https://medicaldigest.org/scien...
QUADRO - A single 4-drug combination in hypertension - report from ESC2024
10 Sep 2024
Contributed by Lukas
Principal Investigator, Professor Stefano Taddei explaining why new treatment strategies are needed for hypertension. He presented in a Hot Line sessi...
The importance of the anterior interface in eye surgery
24 Jul 2024
Contributed by Lukas
Professor Marie-José Tassignon shares her insight on pediatric cataract surgery, she speaks about the importance of anatomical changes in the anterio...
How to treat atherosclerosis? - Highlights of the EAS 2024 (Part II)
16 Jul 2024
Contributed by Lukas
Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis. The second part of our two-part int...
How to treat atherosclerosis? - Highlights of the EAS 2024 (Part I)
16 Jul 2024
Contributed by Lukas
Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis. The first part of our two-part inte...
75th Anniversary of Glucocorticoids - what have we learnt? - report from EULAR2024
10 Jul 2024
Contributed by Lukas
Sytske Anne Bergstra at the recent EULAR 2024 chaired a session on the use of glucocorticoids in the therapy of rheumatoid arthritis. What were the ke...
Early and maintained comparative effectiveness of 5 different classes of advanced therapies in a large multinational cohort of real-world PsA patients - report from EULAR2024
21 Jun 2024
Contributed by Lukas
Professor Dennis McGonagle explains the results of an EULAR 2024 late breaking abstract, the PRO-SPIRIT study, early (3-month) and maintained (12-mont...
Effectiveness of Canakinumab for first line steroid free treatment in systemic juvenile idiopathic arthritis - report from EULAR2024
21 Jun 2024
Contributed by Lukas
Professor Gerd Horneff explains the results of a late breaking abstract from EULAR 2024, effectiveness of canakinumab for first line steroid free trea...
What is New : Osteoporosis in Rheumatology - report from EULAR2024
21 Jun 2024
Contributed by Lukas
Professor Willem Lems share his thoughts on the latest developments in the diagnosis and therapy of osteoporosis as it pertains to the RMDs. Video: ht...
Interstitial Lung Disease: from diagnosis to management - report from EULAR2024
21 Jun 2024
Contributed by Lukas
Professor Anna-Maria Hoffmann-Vold gave us a review of the most recent data from the diagnosis to the management of interstitial lung disease in RMDs....
Promising directions in the treatment of Psoriatic Arthritis - report from EULAR2024
21 Jun 2024
Contributed by Lukas
Professor Rik Lories on the current challenges in prevention and treatment of psoriatic arthritis. Video: https://medicaldigest.org/scientific-conten...
Update of EULAR recommendations for the treatment of Systemic Sclerosis - report from EULAR2024
21 Jun 2024
Contributed by Lukas
Professor Francesco Del Galdo share his thoughts about EULAR Recommendations for the treatment of Systemic Sclerosis. Video: https://medicaldigest.org...
Lupus: what's on the horizon? - report from EULAR2024
20 Jun 2024
Contributed by Lukas
Professor David Isenberg shares an update on novel treatments for lupus and their clinical applications. Video: https://medicaldigest.org/scientific-...
Secukinumab versus standard-of-care in axial spondyloarthritis - report from EULAR2024
20 Jun 2024
Contributed by Lukas
Professor Denis Poddubnyy shared the results of AScalate trial, Secukinumab versus standard-of-care in axial spondyloarthritis, a randomized controlle...
Difficult Questions in Osteoporosis - report from EULAR2024
20 Jun 2024
Contributed by Lukas
Professor Roland Chapurlat shares his experiences on high risk osteoporosis combination terapies, on OP and CKD, as well on pregnancy and OP. Video: h...
Update on EULAR/ACR Project: Risk Stratification in patients with arthralgia suspicious for progression to RA - report from EULAR2024
20 Jun 2024
Contributed by Lukas
Professor Annette H. M. van der Helm van Mil share her thoughts about EULAR Recommendations on risk stratification in patients with arthralgia suspici...
Cardiovascular Comorbidities of Rheumatic and Musculoskeletal Diseases - report from EULAR2024
20 Jun 2024
Contributed by Lukas
Professor Anja Strangfeld chaired an important session during EULAR 2024 on cardiovascular comorbidities of Rheumatic and Musculoskeletal Diseases and...
Fatigue, Pain and Opioids in Rheumatological Diseases - report from EULAR2024
20 Jun 2024
Contributed by Lukas
Professor Rene Westhovens chaired an interesting session during EULAR 2024, where participants learned to recognise the range of pain and fatigue mani...
Asymptomatic ultrasonographic urate deposition in the joint - are there long-term consequences? - report from EULAR2024
19 Jun 2024
Contributed by Lukas
Professor Mariano Andrés on the long-term consequences of asymptomatic urate deposition in the joint. Video: https://medicaldigest.org/scientific-con...
Cardiovascular Risk in Rheumatic & Musculoskeletal Disease - report from EULAR2024
19 Jun 2024
Contributed by Lukas
Professor Michael Nurmohamed shares his experiences on cardiovascular comorbidities of Rheumatic and Musculoskeletal Diseases and their management, as...
"Asymptomatic" Hyperuricemia: Innocent bystander or menacing foe? - report from EULAR2024
19 Jun 2024
Contributed by Lukas
Professor Francisca Sivera chaired an informative session during EULAR 2024, on the long-term consequences of asymptomatic urate deposition in the joi...
Rheumatoid Arthritis Prevention: what have we learnt, and where do we go next? - report from EULAR2024
19 Jun 2024
Contributed by Lukas
Professor Raphael Micheroli chaired an exciting session during EULAR 2024, an update on the results of RA prevention trials to date, describe the less...
Metabolic Reprogramming in Autoimmunity - report from EULAR2024
19 Jun 2024
Contributed by Lukas
Professor Valentina Pucino chaired an interesting session during EULAR 2024 on critical metabolic pathways and the interplay between metabolism and im...
Overview of the 2024 EAS Congress
19 Jun 2024
Contributed by Lukas
We asked Professor Kausik Ray, President of the European Atherosclerosis Society about 2024 EAS Congress and the Society, as well as the Joint Session...
Combination of a beta-blocker with calcium channel blocker in hypertension - report from ESH2024
12 Jun 2024
Contributed by Lukas
Professor Gianfranco Parati share his thoughts on combination of a beta-blocker with calcium channel blocker in hypertension. Video: https://medicaldi...
2023 ESH Hypertension Guideline Update - report from ESH2024
12 Jun 2024
Contributed by Lukas
Professor Rosa de Pinho on 2023 ESH Hypertension Guideline Update. Video: https://medicaldigest.org/scientific-contents/interview:2023-esh-hypertensio...
ESH - ESC HFA Joint meeting: HFpEF update 2024 - report from ESH2024
12 Jun 2024
Contributed by Lukas
Professor Enrico Agabiti Rosei on heart failure with preserved ejection fraction updates at ESH 2024. Video: https://medicaldigest.org/scientific-cont...
ESH guidelines 2023: a new light on beta-blockers in hypertension - report from ESH2024
12 Jun 2024
Contributed by Lukas
Professor Giuseppe Mancia on the update of ESH guidelines 2023. Video: https://medicaldigest.org/scientific-contents/interview:esh-guidelines-2023-new...
Management of older hypertensive patients - report from ESH2024
12 Jun 2024
Contributed by Lukas
Professor Athanase Benetos on how to take care and treat hypertensive older people. Video: https://medicaldigest.org/scientific-contents/interview:man...
Controlling the uncontrollable - resistant hypertension and the role of aldosterone - report from ESH2024
12 Jun 2024
Contributed by Lukas
Professor Michel Azizi on aldosterone receptor blocker versus aldosterone synthase inhibitor. Who is more effective in blocking aldosterone? Video: ht...
How lifestyle affects hypertension - report from ESH2024
11 Jun 2024
Contributed by Lukas
Professor Fadi Charchar on how lifestyle affects hypertension and what a patient could do to prevent hypertension and reduce then blood pressure. Vide...
ESH - ISH Joint Session: Balancing common side effects of Thiazide/Thiazide-like diuretics through addition of other Blood Pressure lowering drugs - report from ESH2024
11 Jun 2024
Contributed by Lukas
Professor Jorie Versmissen and Professor Fadi Charchar discussed the ESH - ISH Joint Session on balancing common side effects of Thiazide/Thiazide-lik...
Beta-blockers in hypertension and CVD - report from ESH2024
11 Jun 2024
Contributed by Lukas
Professor Ricardo Fontes-Carvalho on the role of beta-blockers in the treatment of hypertension and cardiologic diseases. Video: https://medicaldigest...
Diabetes and Metabolic risk factors - report from ESH2024
11 Jun 2024
Contributed by Lukas
Professor Josep Redon chaired an interesting session on Diabetes and Metabolic risk factors at ESH 2024. Video: https://medicaldigest.org/scientific-c...
Nephroprotection using SGLT2 inhibitors in patients with hypertension - report from ESH2024
11 Jun 2024
Contributed by Lukas
Professor Michael Böhm on evolving standard of care and SGLT2 inhibitors for patients with CKD and hypertension. Video: https://medicaldigest.org/sci...
ESH Clinical Practice Guidelines - report from ESH2024
11 Jun 2024
Contributed by Lukas
Professor Roland Schmieder, Co-Chair of ESH 2024 on the ESH 2024 Congress and the updated Guidelines. Video: https://medicaldigest.org/scientific-cont...
Haematology is at the forefront - interview with EHA President
11 Jun 2024
Contributed by Lukas
We asked Professor Antonio Almeida, the President of European Hematology Association about the benefits and perspectives in EHA as a European hematolo...
Obesity induced hypertension - report from ESH2024
10 Jun 2024
Contributed by Lukas
Professor Vasilios Kotsis on obesity induced hypertension and its state of the art treatment. Video: https://medicaldigest.org/scientific-contents/int...
Effect of renal denervation on blood pressure in patients with chronic kidney disease and uncontrolled hypertension - report from ESH2024
10 Jun 2024
Contributed by Lukas
Professor Roland Schmieder on the results of a prospective randomized sham-controlled study and explains the effects of renal denervation on blood pre...
Hypertension and beta-blocker choice: influence of age, stress, and co-morbidities - report from ESH2024
10 Jun 2024
Contributed by Lukas
Professor Sverre Erik Kjeldsen at the recent annual meeting of the European Society of Hypertension, held a lecture on the role of beta-blockers in th...
Overcoming the resistance - Is renal denervation the solution? - report from ESH2024
10 Jun 2024
Contributed by Lukas
Professor Konstantinos Tsioufis shares his thoughts on the novelties of kidney protection in hypertension. Video: https://medicaldigest.org/scientifi...
One heart and two kidneys: Promoting organ protection using SGLT-2 inhibitors in patients with hypertension - report from ESH2024
10 Jun 2024
Contributed by Lukas
Professor Francesca Mallamaci co-chaired a session at the current Annual Congress of the European Society of Hypertension on cardiovascular protective...
Why is it so difficult to reach the expected BP target in real-life patients? - report from ESH2024
06 Jun 2024
Contributed by Lukas
Professor Krzysztof Narkiewicz on why is it so difficult to reach the expected BP target in real-life patients. Video: https://medicaldigest.org/scien...
Time to act to improve adherence in hypertension management: bridging the gap between knowledge and action - report from ESH2024
06 Jun 2024
Contributed by Lukas
Professor Bryan Williams chaired an interesting symposium at ESH 2024. The joint ESH/ESC guideline on the diagnosis and treatment of hypertension and ...
Real-life hypertensive patients: Towards a holistic approach in clinical practice - report from ESH2024
05 Jun 2024
Contributed by Lukas
Professor Claudio Borghi chaired a symposium at ESH 2024 on two very important patient groups, diabetic patients and coronary patients, on antihyperte...
Hypertension and CAD: need of more SPCs - report from ESH2024
05 Jun 2024
Contributed by Lukas
Professor Sofie Brouwers explained at ESH 2024 that antihypertensive treatment for chronic coronary artery disease should be based on an ACE inhibitor...
Challenges in hypertension adherence to treatment - report from ESH2024
05 Jun 2024
Contributed by Lukas
Professor Michel Burnier shared his thoughts on why is adherence is a key factor in good hypertensive management at ESH 2024. Video: https://medicaldi...